paclitaxel has been researched along with Polyneuropathies in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bangemann, N; Blohmer, JU; Boehmerle, W; Dordevic, AD; Endres, M; Göpfert, JC; Hew, L; Huehnchen, P; Kern, J; Körtvelyessy, P; Maierhof, SK; Nolte, L; Ruprecht, K; Schinke, C; Sehouli, J; Somps, CJ | 1 |
| Beutler, AS; Chen, Y; Fang, F; Gersch, CL; Hayes, DF; Henry, NL; Hertz, DL; Kidwell, KM; Lavoie Smith, EM; Marcath, LA; Rae, JM; Vangipuram, K | 1 |
| Aypar, U; Canbay, O; Celebi, N; Cil, H; Cil, O; Onur, R | 1 |
| Boehmerle, W; Endres, M; Huehnchen, P | 1 |
| Banck, MS; Beutler, AS; Beyerlein, P; Boora, GK; Cunningham, JM; Kanwar, R; Klein, CJ; Kulkarni, AA; Le-Lindqwister, NA; Loprinzi, CL; Qin, R; Ruddy, KJ; Schroth, GP; Smalley, RL; Therneau, TM; Windebank, AJ; Wu, Y; Züchner, S | 1 |
| Balkaya, M; Boehmerle, W; Endres, M; Huehnchen, P; Peruzzaro, S | 1 |
| Jones, HR; Srinivasan, J | 1 |
| Auguet, M; Chabrier, PE; Favre-Guilmard, C | 1 |
| Shemesh, OA; Spira, ME | 1 |
| Reilich, P; Schessl, J; Schlotter-Weigel, B; Schneiderat, P; Schoser, B; Schuberth, M; Strigl-Pill, N; Walter, MC | 1 |
| Friedlander, ML; Kiernan, MC; Krishnan, AV; Lewis, CR; Lin, CS; Park, SB | 1 |
| Carozzi, V; Cavaletti, G; Hayakawa, K; Hosokawa, S; Lapidus, RG; Littlefield, BA; Nomoto, K; Slusher, BS; Towle, MJ; Wozniak, KM; Wu, Y | 1 |
| Carmeliet, P; Daniels, A; Dhondt, J; Lambrechts, D; Meert, T; Nuydens, R; Peeraer, E; Pintelon, I; Poesen, K; Timmermans, JP; Verheyen, A | 1 |
| Antman, K; Balmaceda, C; Donovan, D; Frederick, D; Haythe, J; Hesdorffer, CS; Kaufman, E; Nichols, G; Papadopoulos, K; Savage, D; Sharpe, E; Tiersten, A; Troxel, A; Vahdat, LT | 1 |
| Gedlicka, C; Kornek, GV; Scheithauer, W; Schmid, K | 1 |
| Berghmans, T; Klastersky, J; Lafitte, JJ; Mommen, P; Ninane, V; Paesmans, M; Recloux, P; Richez, M; Sculier, JP; Van Cutsem, O | 1 |
4 trial(s) available for paclitaxel and Polyneuropathies
| Article | Year |
|---|---|
Genetic variation in Charcot-Marie-Tooth genes contributes to sensitivity to paclitaxel-induced peripheral neuropathy.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Charcot-Marie-Tooth Disease; Cohort Studies; Female; Genetic Variation; Humans; Male; Middle Aged; Paclitaxel; Polyneuropathies; Prospective Studies | 2020 |
Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cyclophosphamide; Female; Granulocyte Colony-Stimulating Factor; Humans; Melphalan; Middle Aged; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Polyneuropathies; Remission Induction; Survival Analysis; Survival Rate; Thiotepa | 2002 |
Amelioration of docetaxel/cisplatin induced polyneuropathy by alpha-lipoic acid.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Cisplatin; Docetaxel; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Paclitaxel; Polyneuropathies; Taxoids; Thioctic Acid | 2003 |
A phase II study testing paclitaxel as second-line single agent treatment for patients with advanced non-small cell lung cancer failing after a first-line chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Polyneuropathies; Survival; Treatment Outcome | 2002 |
12 other study(ies) available for paclitaxel and Polyneuropathies
| Article | Year |
|---|---|
Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy.
Topics: Antineoplastic Agents; Biomarkers; Cohort Studies; Humans; Neurofilament Proteins; Paclitaxel; Peripheral Nervous System Diseases; Polyneuropathies | 2022 |
Protective effect of coenzyme Q10 in paclitaxel-induced peripheral neuropathy in rats.
Topics: Animals; Hyperalgesia; Male; Paclitaxel; Pain Threshold; Physical Stimulation; Polyneuropathies; Rats; Rats, Sprague-Dawley; Touch; Ubiquinone | 2013 |
Assessment of paclitaxel induced sensory polyneuropathy with "Catwalk" automated gait analysis in mice.
Topics: Amines; Animals; Antineoplastic Agents; Automation; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Gabapentin; Gait; gamma-Aminobutyric Acid; Male; Mice; Mice, Inbred C57BL; Paclitaxel; Peripheral Nervous System; Polyneuropathies | 2013 |
Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy.
Topics: Alleles; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Charcot-Marie-Tooth Disease; Female; Humans; Male; Middle Aged; Mutation; Neoplasms; Paclitaxel; Polyneuropathies; Prospective Studies; Rho Guanine Nucleotide Exchange Factors | 2014 |
Electrophysiological, behavioral and histological characterization of paclitaxel, cisplatin, vincristine and bortezomib-induced neuropathy in C57Bl/6 mice.
Topics: Action Potentials; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Behavior, Animal; Boronic Acids; Bortezomib; Cisplatin; Electrophysiology; Gait; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Paclitaxel; Polyneuropathies; Pyrazines; Vincristine | 2014 |
Sensory polyneuropathy associated with paclitaxel-eluting coronary stent.
Topics: Aged; Angina, Unstable; Angioplasty, Balloon; Coronary Restenosis; Disease Susceptibility; Drug-Eluting Stents; Humans; Male; Neural Conduction; Paclitaxel; Paresthesia; Polyneuropathies; Recurrence; Sensation Disorders; Sjogren's Syndrome | 2009 |
Different antinociceptive effects of botulinum toxin type A in inflammatory and peripheral polyneuropathic rat models.
Topics: Analgesics; Animals; Botulinum Toxins, Type A; Carrageenan; Dantrolene; Disease Models, Animal; Edema; Hyperalgesia; Inflammation; Injections; Male; Motor Activity; Paclitaxel; Polyneuropathies; Rats; Rats, Sprague-Dawley | 2009 |
Paclitaxel induces axonal microtubules polar reconfiguration and impaired organelle transport: implications for the pathogenesis of paclitaxel-induced polyneuropathy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Aplysia; Axons; Biological Transport; Image Processing, Computer-Assisted; Microscopy, Confocal; Microtubules; Organelles; Paclitaxel; Polyneuropathies | 2010 |
Long-term efficiency of intravenously administered immunoglobulin in anti-Yo syndrome with paraneoplastic cerebellar degeneration.
Topics: Aged; Antineoplastic Agents; Carboplatin; Female; Humans; Immunoglobulins, Intravenous; Ovarian Neoplasms; Paclitaxel; Paraneoplastic Cerebellar Degeneration; Polyneuropathies | 2011 |
Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxel-induced neuropathy.
Topics: Adult; Axons; Breast Neoplasms; Disease Progression; Female; Humans; Membrane Potentials; Middle Aged; Paclitaxel; Polyneuropathies; Prospective Studies; Sensory Receptor Cells; Time Factors | 2011 |
Comparison of neuropathy-inducing effects of eribulin mesylate, paclitaxel, and ixabepilone in mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Body Weight; Dose-Response Relationship, Drug; Epothilones; Female; Furans; Ganglia, Spinal; Ketones; Mesylates; Mice; Mice, Inbred BALB C; Neural Conduction; Paclitaxel; Polyneuropathies; Rats; Sciatic Nerve; Tubulin Modulators | 2011 |
Systemic anti-vascular endothelial growth factor therapies induce a painful sensory neuropathy.
Topics: Animals; Antibodies, Neutralizing; Behavior, Animal; Ganglia, Spinal; Indoles; Mice; Mice, Transgenic; Neuralgia; Neurons; Paclitaxel; Pain Measurement; Polyneuropathies; Protein Kinase Inhibitors; Pyrroles; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2012 |